Skip to main content

Research Repository

Advanced Search

Triggers of Breathlessness in Inducible Laryngeal Obstruction and Asthma (2020)
Journal Article
Haines, J., Chua, S. H., Smith, J., Slinger, C., Simpson, A. J., & Fowler, S. J. (2020). Triggers of Breathlessness in Inducible Laryngeal Obstruction and Asthma. Clinical and Experimental Allergy, 50(11), 1230-1237. https://doi.org/10.1111/cea.13715

Background Inducible laryngeal obstruction (ILO) is often misdiagnosed as, or may coexist with, asthma. Identifying differences in triggering factors may assist clinicians to differentiate between the two conditions, and could give mechanistic insig... Read More about Triggers of Breathlessness in Inducible Laryngeal Obstruction and Asthma.

A standard, single dose of inhaled terbutaline attenuates hyperpnea-induced bronchoconstriction and mast cell activation in athletes (2016)
Journal Article
Simpson, A. J., Bood, J. R., Anderson, S. D., Romer, L. M., Dahlén, B., Dahlén, S. E., & Kippelen, P. (2016). A standard, single dose of inhaled terbutaline attenuates hyperpnea-induced bronchoconstriction and mast cell activation in athletes. Journal of Applied Physiology, 120(9), 1011-1017. https://doi.org/10.1152/japplphysiol.00700.2015

Release of bronchoactive mediators from mast cells during exercise hyperpnea is a key factor in the pathophysiology of exercise-induced bronchoconstriction (EIB). Our aim was to investigate the effect of a standard, single dose of an inhaled β 2 -adr... Read More about A standard, single dose of inhaled terbutaline attenuates hyperpnea-induced bronchoconstriction and mast cell activation in athletes.